Langerhans cell histiocytosis associated with chronic myelomonocytic leukaemia both harbouring the same BRAF V600E mutation: efficacy of vemurafenib
Maria Polina Konstantinou, P. Lucas, C. Uthurriague, M. Severino‐Freire, N. Spenatto, Christophe Gaudin, Laurence Lamant, É. Tournier, C. Bulaï Livideanu, Nicole Meyer, C. Paul
Topics & Concepts
MedicineVemurafenibUniversity hospitalDermatologyCancerFamily medicineInternal medicineMetastatic melanomaHistiocytic Disorders and TreatmentsViral-associated cancers and disordersVascular Malformations and Hemangiomas